⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT March 24, 2026

Willfact 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 1000 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)

📷 EU Safety Watch placeholder
Willfact 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 1000 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)
📷 EU Safety Watch placeholder

Willfact 1000 IU powder and solvent for solution for injection 1000 IU (powder and solvent for solution for injection) Reason: manufacturing capacity shortages

Marketing authorisation holder
Lfb Biomedicaments, 3 Avenue Des Tropiques Bp 40305 Les Ulis Les Ulis -, 91958 Courtaboeuf Cedex, French Republic
Affected packs
1 unit box, vial, vial [limited availability, since 2026-03-04]
⚠️
Shortage ongoing
VON WILLEBRAND FAKTOR AUS MENSCHLICHEM PLASMA is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a powder and liquid that are mixed to make an injection. It contains a clotting factor from human blood. It is used to treat a bleeding disorder.

What's happening? There is a short supply because the factory cannot make enough. Some packs are hard to find in Austria.

Does this affect me? If you use this medicine, you may have trouble getting it right now.

What should I do? Ask your pharmacist or doctor for advice before you run out.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

ATC: B02BD10 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Lfb Biomedicaments, 3 Avenue Des Tropiques Bp 40305 Les Ulis Les Ulis -, 91958 Courtaboeuf Cedex, French Republic · Affected packs: 1 Stück Schachtel, Durchstechflasche, Durchstechflasche [eingeschränkt verfügbar, since 2026-03-04]

First published
March 24, 2026
Last refreshed by us
1 week ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Willfact 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 1000 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung). Willfact 1000 IU powder and solvent for solution for injection 1000 IU (powder and solvent for solution for injection) Reason: manufacturing capacity shortages · Marketing authorisation holder: Lfb Biomedicaments, 3 Avenue Des Tropiques Bp 40305 Les Ulis Les Ulis -, 91958 Courta...
When was this alert issued?
This alert was issued on March 24, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.